Platform forecasts COVID-19 trial outcomes
Previous studies reportedly demonstrated that, on average, only 13.8% of all drugs in Phase I clinical trials eventually win approval from regulators and …
Previous studies reportedly demonstrated that, on average, only 13.8% of all drugs in Phase I clinical trials eventually win approval from regulators and …